Updating a systematic review – what difference did it make? Case study of nicotine replacement therapy
نویسندگان
چکیده
AIMS To examine the effect of updating a systematic review of nicotine replacement therapy on its contents and conclusions. METHODS We examined the effects of regular updating of a systematic review of nicotine replacement therapy for smoking cessation. We considered two outcomes. First, we assessed the effect of adding new data to meta-analyses, comparing results in 2000 with the results in 1994. Second, we assessed qualitatively the ways in which the nature of the questions addressed by the review had changed between the two dates. For the first outcome, we compared the number of trials, the pooled estimate of effect using the odds ratio, and the results of pre-specified subgroup analyses, for nicotine gum and patch separately. Using a test for interaction, we assessed whether differences between estimates were statistically significant. RESULTS There were ten new trials of nicotine gum between 1994 and 2000, and the meta-analytic effect changed little. For the nicotine patch the number of trials increased from 9 to 30, and the meta-analytic effect fell from 2.07 (95% CI 1.64 - 2.62) to 1.73 (95% CI 1.56 - 1.93). Apparent differences in relative effect in sub-groups found in 1994 were not found in 2000. The updated systematic review addressed a number of questions not identified in the original version. CONCLUSIONS Updating the meta-analyses lead to a more precise estimate of the likely effect of the nicotine patch, but the clinical message was unchanged. Further placebo controlled NRT trials are not likely to add to the evidence base. It is questionable whether updating the meta-analyses to include them is worthwhile. The content of the systematic review has, however, changed, with the addition of data addressing questions not considered in the original review. There is a tension between the principle of identifying the important questions prior to conducting a review, and keeping the review up to date as primary research identifies new avenues of enquiry.
منابع مشابه
Scanning the Global Literature
cYTISINE VS NIcOTINE FOr SmOkING cESSaTION This randomized, pragmatic, open-labeled trial conducted in New Zealand compared cytisine against nicotine replacement therapy in a sample of 1310 adult daily smokers who had called the national quitline for support. Cytisine is a plant-based alkaloid similar to varenicline and acts on the same nicotinic acetylcholine receptors. Four previous systemati...
متن کاملNicotine Replacement Therapy in Dental Settings: An Exploratory Survey in Bangalore City, India
Background: Smoking and other forms of tobacco use remain the most significant worldwide public health problem. The dental practice is being identified as potential location for smoking cessation activity. Nicotine replacement therapy (NRT) promotes the chances of tobacco cessation, however, evidence related to prescription of the NRT in dental settings is lacking. This study aimed to assess an...
متن کاملHelping hospital patients quit: what the evidence supports and what guidelines recommend.
OBJECTIVE The study aimed to critically appraise the extent and strength of systematic review evidence for, and guideline recommendations regarding hospital smoking cessation interventions. METHODS Systematic reviews of smoking cessation interventions were identified via an electronic search of the Cochrane Library. Meta-analyses from Cochrane reviews were categorised as those that incorporat...
متن کاملEffectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis
OBJECTIVE To determine the effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking. DESIGN Systematic review of randomised controlled trials. DATA SOURCES Cochrane Library, Medline, Embase, CINAHL, PsychINFO, Science Citation Index, registries of ongoing trials, reference lists, the drug company that sponsored most of the trials, and clinical experts. Rev...
متن کاملMecamylamine (a nicotine antagonist) for smoking cessation.
BACKGROUND Mecamylamine is a nicotine antagonist (that is it blocks the effect of nicotine). The rationale for its use in smoking cessation is that it may block the rewarding effect of nicotine and thus reduce the urge to smoke. OBJECTIVES The objective of this review was to determine the effectiveness of mecamylamine in promoting smoking cessation, either alone or in combination with nicotin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMC Medical Research Methodology
دوره 1 شماره
صفحات -
تاریخ انتشار 2001